Avantor, Inc.

Avantor, Inc.

AVTRยทNYSE

$9.07

+2.1%
HealthcareMedical - Instruments & Supplies

Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.

At a Glance

Live Snapshot
Market Cap$6.19B
EPS-0.7800
P/E Ratio-11.63
Earnings Date08/07/2026
3Y-13.0%
5Y+2.0%
10Y+848.0%
3Y-177.0%
5Y-555.0%
10Y+1150.0%
3Y-26.0%
5Y-33.0%
10Y+756.0%
Avantor, Inc.

Avantor, Inc. Profit Bridge

AVTR ยท NYSE
Revenue6.55B
Cost of Goods Sold (4.41B)
Gross Profit2.14B
Operating Expenses (2.39B)
Operating Income-246.20M
Interest Expense (169.80M)
Other Income/Expense-195.10M
Pretax Income-441.30M
Income Tax (88.90M)
Net Income-530.20M
Net Income
-530.20M

Profitability Analysis

Gross Margin

32.7%

Moderate margins typical of competitive industries. Monitor for pricing pressure or rising costs.

Operating Margin

-3.8%

Operating losses indicate the core business is unprofitable. Requires restructuring or revenue growth.

Net Profit Margin

-8.1%

Net losses indicate the company is burning cash. Sustainability depends on path to profitability.

Profitability Insight

Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.

Avantor, Inc. Income Statement

AVTR โ€ข NYSE

Avantor, Inc. Income StatementDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015
REVENUE
6.6B
6.8B
7B
7.5B
7.4B
6.4B
6B
5.9B
1.2B
691.3M
636.9M
GROSS PROFIT
(4.4B)
(4.5B)
(4.6B)
(4.9B)
(4.9B)
(4.3B)
(4.1B)
(4B)
(814.6M)
(371.6M)
(374.7M)
2.1B
2.3B
2.4B
2.6B
2.5B
2.1B
1.9B
1.8B
432.8M
319.7M
262.2M
OPERATING INCOME
(2.4B)
(1.2B)
(1.7B)
(1.5B)
(1.5B)
(1.4B)
(1.4B)
(1.4B)
(643.2M)
(309.8M)
(201.9M)
(1.6B)
(1.6B)
(1.5B)
(1.5B)
(1.5B)
(1.4B)
(1.4B)
(1.4B)
(643.2M)
(309.8M)
(201.6M)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(19.1M)
(21.9M)
-246.2M
1.1B
696.4M
1.1B
972.2M
706.8M
551.8M
413.5M
-210.4M
9.9M
60.3M
PRE-TAX INCOME
(169.8M)
(218.8M)
(284.8M)
(265.8M)
(217.4M)
(307.6M)
(440M)
(523.8M)
(200.9M)
(80.3M)
(0.0)
-169.8M
-218.8M
-284.8M
-265.8M
-217.4M
-307.6M
-440M
-523.8M
-200.9M
-80.3M
0.0
(790.1M)
-446.6M
(160.8M)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
-300K
-195.1M
-230.9M
-285.9M
-279.1M
-219.2M
-644.5M
-511.2M
-527.3M
-249.8M
-80.5M
-30.5M
-441.3M
853.9M
410.5M
851.1M
753M
62.3M
40.6M
-113.8M
-460.2M
-70.6M
29.8M
NET INCOME
(88.9M)
(142.4M)
(89.4M)
(164.6M)
(180.4M)
-54.3M
(2.8M)
-26.9M
-314.9M
(10.1M)
(17.1M)
-530.2M
711.5M
321.1M
686.5M
572.6M
116.6M
37.8M
-86.9M
-112.7M
-42.4M
21.6M

SEC Filings

AVTR - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
8-K

8-K 2026

N/A

May 12, 2026
May 07, 2026
2026
10-Q

10-Q 2026 Q1

Q1

April 29, 2026
March 31, 2026
2026
8-K

8-K 2026

N/A

April 29, 2026
April 29, 2026
2026
8-K

8-K 2026

N/A

April 23, 2026
April 17, 2026
2026
8-K

8-K 2026

N/A

April 01, 2026
March 26, 2026
2026
DEF 14A

DEF 14A 2026

N/A

March 27, 2026
May 07, 2026
2026
8-K/A

8-K/A 2025 (Amended)

N/A

February 25, 2026
December 17, 2025
2025
8-K/A

8-K/A 2025 (Amended)

N/A

February 25, 2026
December 04, 2025
2025
8-K

8-K 2026

N/A

February 11, 2026
February 11, 2026
2026
10-K

10-K 2025 FY

FY

February 11, 2026
December 31, 2025
2025
Showing 1 to 10 of 144 filings